WallStreetZenWallStreetZen

NASDAQ: BNR
Burning Rock Biotech Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their BNR stock forecasts and price targets.

Forecast return on equity

Is BNR forecast to generate an efficient return?

Company
N/A
Industry
8.44%
Market
329.83%

Forecast return on assets

Is BNR forecast to generate an efficient return on assets?

Company
N/A
Industry
9.95%

BNR earnings per share forecast

What is BNR's earnings per share in the next 1 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$7.17

BNR revenue forecast

What is BNR's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$1.2B+1,509.43%
Avg 2 year Forecast
$1.1B+1,407.77%
BNR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BNR revenue growth forecast

How is BNR forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
1,509.43%
Industry
3.18%
Market
1,453.97%
BNR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BNR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BNR vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
BNR$15.75N/AN/A
XGN$7.11$15.00+110.97%Strong Buy
IMDX$5.22$9.00+72.58%Buy
SERA$3.51N/AN/A
PRE$14.86$32.00+115.42%Strong Buy
View Top Diagnostic & Research Stocks

Burning Rock Biotech Stock Forecast FAQ

What is BNR's earnings growth forecast for 2025-2025?

(NASDAQ: BNR) Burning Rock Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 35.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,953.18%.

Burning Rock Biotech's earnings in 2025 is -$17,030,056.

In 2025, BNR is forecast to generate -$772,107,675 in earnings, with the lowest earnings forecast at -$749,169,517 and the highest earnings forecast at -$802,684,703.

If you're new to stock investing, here's how to buy Burning Rock Biotech stock.

What is BNR's revenue growth forecast for 2025-2026?

(NASDAQ: BNR) Burning Rock Biotech's forecast annual revenue growth rate of 1,509.43% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.18%, and it is also forecast to beat the US market's average forecast revenue growth rate of 1,453.97%.

Burning Rock Biotech's revenue in 2025 is $75,740,870.On average, 3 Wall Street analysts forecast BNR's revenue for 2025 to be $131,336,848,273, with the lowest BNR revenue forecast at $111,189,193,944, and the highest BNR revenue forecast at $153,854,814,876.

In 2026, BNR is forecast to generate $123,040,755,314 in revenue, with the lowest revenue forecast at $119,377,545,436 and the highest revenue forecast at $127,889,121,329.

What is BNR's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: BNR) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 9.95%.

What is BNR's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: BNR) Burning Rock Biotech's current Earnings Per Share (EPS) is -$1.64. In 2025, BNR's EPS is forecast to hit -$7.17 (min: -$6.95, max: -$7.45).

What is BNR's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: BNR) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.